Clinical Trial Update: Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating maribavir for cytomegalovirus infection in patients with lymphoid malignancies on bispecific antibodies; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Maribavir (maribavir)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Cytomegalovirus (CMV) | Phase 2 | Status: RECRUITING